Nat Clin Pract Cardiovasc Med. 2008;5(12):764-765. We believe that strategies to avoid or reduce the severity of PPM should be individualized and take into account multiple variables, such as ...

The following is a summary of “Computed tomography derived predictors of left ventricular obstruction after TAVR,” published ...

Barclays analyst initiates Positive coverage on Anteris Technologies, forecasting a 4%-5% U.S. TAVR market share for DurAVR ...

North America to Lead Revenue While Asia Pacific Emerges as the Fastest-Growing Region, Driven by Rising Cardiovascular Cases ...

Lipoprotein(a) doesn’t influence calcification or outcomes in TAVR, shifting focus to other AS progression factors.

THE SOLVE-TAVI trial demonstrated that both valve type and anaesthesia strategy yielded comparable long-term outcomes in ...

Raipur: The cardio surgery department of state-run Dr Bhimrao Ambedkar Memorial Hospital successfully performed a challenging open heart surgery on a .

Barclays analyst Matt Miksic initiated coverage of Anteris Technologies (AVR) with an Overweight rating and $22 price target The timing for ...

US-based Lantheus Holdings becomes largest shareholder in Radiopharm Theranostics after US$5 million private placement.

Cantor Fitzgerald analyst Ross Osborn initiated coverage of Anteris Technologies (AVR) with an Overweight rating and $9 price target Anteris ...